Cite
Landolf KM, Lemieux SM, Rose C, et al. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review. Pharmacotherapy. 2021;doi: 10.1002/phar.2637.
Landolf, K. M., Lemieux, S. M., Rose, C., Johnston, J. P., Adams, C. D., Altshuler, J., Berger, K., Dixit, D., Effendi, M. K., Heavner, M. S., Lemieux, D., Littlefield, A. J., Nei, A. M., Owusu, K. A., Rinehart, M., Robbins, B., Rouse, G. E., & Thompson Bastin, M. L. (2021). Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review. Pharmacotherapy, . https://doi.org/10.1002/phar.2637
Landolf, Kaitlin M, et al. "Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review." Pharmacotherapy vol. (2021). doi: https://doi.org/10.1002/phar.2637
Landolf KM, Lemieux SM, Rose C, Johnston JP, Adams CD, Altshuler J, Berger K, Dixit D, Effendi MK, Heavner MS, Lemieux D, Littlefield AJ, Nei AM, Owusu KA, Rinehart M, Robbins B, Rouse GE, Thompson Bastin ML. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review. Pharmacotherapy. 2021 Oct 18; doi: 10.1002/phar.2637. Epub 2021 Oct 18. PMID: 34662448; PMCID: PMC8662062.
Copy
Download .nbib